STOCK TITAN

The Cigna Group's Fourth Quarter 2025 Earnings Release Details

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

The Cigna Group (NYSE:CI) will release fourth quarter 2025 financial results on Thursday, February 5, 2026, with the results posted no later than 6:30 a.m. ET. Management will review results on a conference call beginning at 8:30 a.m. ET the same day.

Live dial-in: (888) 566-1889 (Domestic) and (773) 799-3989 (International), passcode 02052026. Replay: (866) 405-7290 (Domestic) and (203) 369-0603 (International), available from 12:30 p.m. ET Feb 5, 2026 until 10:59 p.m. ET Feb 19, 2026. A live webcast (listen-only) will be available in the Investor Relations section of the company website, and the news release plus financial supplement will be posted there by 6:30 a.m. ET Feb 5, 2026.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-1.53%
1 alert
-1.53% News Effect

On the day this news was published, CI declined 1.53%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: February 5, 2026 Results release time: 6:30 a.m. ET Conference call time: 8:30 a.m. ET +5 more
8 metrics
Earnings release date February 5, 2026 Q4 2025 financial results release
Results release time 6:30 a.m. ET Q4 2025 results available by this time
Conference call time 8:30 a.m. ET Management call to review Q4 2025 results
Replay window start 12:30 p.m. ET, Feb 5, 2026 Earnings call replay availability begins
Replay window end 10:59 p.m. ET, Feb 19, 2026 Earnings call replay availability ends
Domestic live call (888) 566-1889 U.S. dial-in for Q4 2025 earnings call
International live call (773) 799-3989 International dial-in for Q4 2025 earnings call
Passcode 02052026 Access code for Q4 2025 earnings conference call

Market Reality Check

Price: $271.00 Vol: Volume 1,526,994 vs 20-da...
normal vol
$271.00 Last Close
Volume Volume 1,526,994 vs 20-day average 1,517,129 (relative volume 1.01x) indicates typical trading ahead of the notice. normal
Technical Shares at $276.02 are trading below the 200-day MA of $299.05 and about 21.14% under the 52-week high.

Peers on Argus

CI was down 1.05% while major peers were mixed: CVS -0.48%, ELV +0.02%, HUM -0.0...

CI was down 1.05% while major peers were mixed: CVS -0.48%, ELV +0.02%, HUM -0.05%, CNC +1.96%, MOH +0.16%, suggesting stock-specific trading rather than a sector-wide move.

Historical Context

5 past events · Latest: Jan 07 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Jan 07 Onsite clinic launch Positive -2.0% Opened Hankook Tire clinic powered by Evernorth for employees and families.
Dec 10 Veterans grants Positive -0.0% Announced $3M in local grants within a $9M veteran mental health initiative.
Dec 03 Vitality research Neutral -1.4% Released 2025 Vitality in America report on purpose and health outcomes.
Nov 12 Conference appearance Neutral +1.0% Announced management presentation at UBS Global Healthcare Conference.
Nov 10 Headspace rollout Positive -2.4% Launched Headspace for Cigna Healthcare to expand mental health support.
Pattern Detected

Recent non-earnings news skewed positive or strategic, yet price reactions were often slightly negative, indicating a pattern of muted or contrary responses to favorable headlines.

Recent Company History

Over the last several months, The Cigna Group issued a series of operating and community-impact updates. These included an onsite clinic launch at Hankook’s Tennessee plant (Jan 7, 2026), additional $3 million in veterans’ mental health grants, and research on vitality and purpose. The company also highlighted investor-facing activities like the UBS Global Healthcare Conference appearance and the Headspace collaboration for mental health support. Despite generally constructive themes, share reactions around these items were modest and often negative.

Regulatory & Risk Context

Active S-3 Shelf
Shelf Active
Active S-3 Shelf Registration 2025-09-02

The company has an effective S-3ASR shelf filed on 2025-09-02, registering securities for potential public offerings, including detailed terms for debt securities and related covenants. A 424B5 filing on the same date indicates at least one usage of this shelf. Specific dollar amounts are not provided here.

Market Pulse Summary

This announcement sets the timing for The Cigna Group’s Q4 2025 results on February 5, 2026, with de...
Analysis

This announcement sets the timing for The Cigna Group’s Q4 2025 results on February 5, 2026, with details before 6:30 a.m. ET and a management call at 8:30 a.m. ET. It follows a consistent pattern of advance earnings notices seen throughout 2025. Given prior quarters featured double-digit revenue growth and reaffirmed or raised adjusted EPS outlooks, investors will likely focus on how Q4 metrics compare and whether full-year guidance is updated.

AI-generated analysis. Not financial advice.

BLOOMFIELD, Conn., Jan. 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2025 financial results on Thursday, February 5, 2026, and will host a conference call the same day.

Fourth quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:

Live Call
(888) 566-1889 (Domestic)
(773) 799-3989 (International)
Passcode: 02052026

Replay
(866) 405-7290 (Domestic)
(203) 369-0603 (International)

It is strongly suggested that participants dial in to the conference call by 8:15 a.m. ET on February 5, 2026. A replay of the call will be available from 12:30 p.m. ET on February 5, 2026 until 10:59 p.m. ET on February 19, 2026. Additionally, the conference call will be available on a live internet webcast at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website. Please note that this feature will be in listen-only mode.

A copy of the company's news release and financial supplement will be available on The Cigna Group's website in the Investor Relations section at https://investors.thecignagroup.com/overview/default.aspx, no later than 6:30 a.m. ET on February 5, 2026.

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has approximately 180 million customer relationships around the world. Learn more at thecignagroup.com.

Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
Ralph.Giacobbe@TheCignaGroup.com

Media Contact
Justine Sessions
1 (860) 810-6523
Justine.Sessions@Evernorth.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-cigna-groups-fourth-quarter-2025-earnings-release-details-302658992.html

SOURCE The Cigna Group

FAQ

When will The Cigna Group (CI) release Q4 2025 results?

The Cigna Group will release Q4 2025 results on February 5, 2026, posted no later than 6:30 a.m. ET.

What time and passcode is the Cigna (CI) Q4 2025 conference call?

The call begins at 8:30 a.m. ET on Feb 5, 2026; passcode 02052026.

How can I listen to the live webcast of Cigna (CI) Q4 2025 results?

The webcast will be available in the Investor Relations section at the company's website in listen-only mode.

What are the dial-in numbers for Cigna (CI) Q4 2025 earnings call?

Live domestic: (888) 566-1889; international: (773) 799-3989.

When is the replay available for The Cigna Group (CI) Q4 2025 call?

Replay is available from 12:30 p.m. ET on Feb 5, 2026 until 10:59 p.m. ET on Feb 19, 2026 with domestic number (866) 405-7290.
Cigna Group

NYSE:CI

CI Rankings

CI Latest News

CI Latest SEC Filings

CI Stock Data

72.61B
262.69M
1.59%
90.15%
1.14%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
BLOOMFIELD